Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Boeing
BA
|
+$1.54B |
| 2 |
D.R. Horton
DHI
|
+$1.12B |
| 3 |
NVIDIA
NVDA
|
+$967M |
| 4 |
Netflix
NFLX
|
+$943M |
| 5 |
GE Aerospace
GE
|
+$924M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.58B |
| 2 |
Apple
AAPL
|
+$1.54B |
| 3 |
Amazon
AMZN
|
+$1.47B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.43B |
| 5 |
Microsoft
MSFT
|
+$1.22B |
Sector Composition
| 1 | Technology | 18.98% |
| 2 | Healthcare | 17.33% |
| 3 | Industrials | 12.85% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Financials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
AvidXchange
AVDX
$2.07B
| $69.6M | 0.02% |
6,999,655
-2,227
| -0% | -$22.1K |
|
302
Eastern Bankshares
EBC
$3.39B
| $69.2M | 0.02% |
4,010,414
+464,974
| +13% | +$8.02M |
|
303
Fastenal
FAST
$54.5B
| $68.8M | 0.02% |
+2,908,092
| New | +$68.8M |
|
304
Levi Strauss
LEVI
$8.87B
| $66.7M | 0.02% |
4,295,300
+1,345,300
| +46% | +$20.9M |
|
305
Floor & Decor
FND
$9.59B
| $66.2M | 0.02% |
+950,690
| New | +$66.2M |
|
306
Emerson Electric
EMR
$73.5B
| $65.7M | 0.02% |
683,618
| – | – |
|
307
First Advantage
FA
$2.73B
| $64.8M | 0.02% |
4,988,399
+2,031,487
| +69% | +$26.4M |
|
308
ICF International
ICFI
$1.84B
| $64.8M | 0.02% |
653,831
+562,165
| +613% | +$55.7M |
|
309
Silicon Laboratories
SLAB
$4.4B
| $63M | 0.02% |
464,000
| – | – |
|
310
Denali Therapeutics
DNLI
$1.94B
| $62.9M | 0.02% |
2,260,642
+2,172,875
| +2,476% | +$60.4M |
|
311
New York Times
NYT
$9.34B
| $62.1M | 0.02% |
1,914,638
+100,000
| +6% | +$3.25M |
|
312
GSK
GSK
$81.1B
| $61.5M | 0.02% |
1,750,178
-88
| -0% | -$3.09K |
|
313
Newmont
NEM
$86.4B
| $59M | 0.02% |
1,250,000
| – | – |
|
|
BRSL
314
Brightstar Lottery PLC
BRSL
$3.18B
| $57.7M | 0.02% |
2,544,149
+122,549
| +5% | +$2.78M |
|
315
PotlatchDeltic
PCH
$3.13B
| $56.8M | 0.02% |
1,290,200
+910,900
| +240% | +$40.1M |
|
316
Dow Inc
DOW
$17.5B
| $55.7M | 0.02% |
1,106,174
+274
| +0% | +$13.8K |
|
317
Lennar Class A
LEN
$34B
| $54.6M | 0.02% |
+623,780
| New | +$54.6M |
|
|
SBNY
318
DELISTED
Signature Bank
SBNY
| $54.6M | 0.02% |
473,874
| – | – |
|
319
Guardant Health
GH
$6.72B
| $54.4M | 0.02% |
2,001,782
-148,722
| -7% | -$4.05M |
|
320
Fiserv
FI
$72.2B
| $54.2M | 0.02% |
536,700
| – | – |
|
|
CHX
321
DELISTED
ChampionX
CHX
| $53.7M | 0.02% |
1,851,762
+1,389,137
| +300% | +$40.3M |
|
322
Schlumberger
SLB
$52.3B
| $53.3M | 0.02% |
+996,431
| New | +$53.3M |
|
323
Sempra
SRE
$54.4B
| $53.3M | 0.02% |
689,378
+1,050
| +0.2% | +$81.1K |
|
324
Atkore
ATKR
$2.08B
| $52.9M | 0.02% |
466,155
+29,955
| +7% | +$3.4M |
|
325
SiriusPoint
SPNT
$2.11B
| $52.2M | 0.02% |
8,850,000
+5,285,701
| +148% | +$31.2M |
|